DOI QR코드

DOI QR Code

Relationships between Household Smoking Restrictions and Intention to Quit Smoking among Korean American Male Smokers in California

  • Myung, Seung-Kwon (Smoking Cessation Clinic, Center for Cancer Prevention and Detection, National Cancer Center & Division of Cancer Prevention, National Cancer Control Research Institute, National Cancer Center) ;
  • McDonnell, Diana D. (Center for Family and Community Health, School of Public Health, University of California) ;
  • Kazinets, Gene (Center for Family and Community Health, School of Public Health, University of California) ;
  • Seo, Hong-Gwan (Smoking Cessation Clinic, Center for Cancer Prevention and Detection, National Cancer Center & Division of Cancer Prevention, National Cancer Control Research Institute, National Cancer Center) ;
  • Moskowitz, Joel M. (Center for Family and Community Health, School of Public Health, University of California)
  • Published : 2010.02.01

Abstract

This cross-sectional study examined the relationships between household smoking restrictions and intentions to quit smoking among Korean American male smokers in California. We used data from the California Korean American Tobacco Use Survey (CKATUS), which was conducted in 2004 using computer-assisted telephone interviewing. Among the 2,545 respondents who participated in the CKATUS, the 387 male smokers who answered a question assessing their intention to quit smoking were included in the final analyses. In univariable analyses, smokers who reported having household smoking restrictions were more likely to intend to quit smoking as compared with those who did not (P<0.01). Other independent correlates of having an intention to quit smoking were being less than 50 yr of age, having spent more than 50% of one's life in the US, being assimilated, and having other smokers in the household. In a multiple logistic regression analysis, the significant correlates of having an intention to quit smoking were household smoking restrictions (complete or partial restriction vs. no restriction on smoking; odds ratio, 2.54;95% confidence interval, 1.22-5.28) and absence of other smokers in the household. In conclusion, smoking restrictions in the household are associated with an intention to quit smoking among Korean American male smokers in California.

Keywords

References

  1. Cianfrocca M, Goldstein LJ. Prognostic and predictive factors in early-stage breast cancer. Oncologist 2004; 9: 606-16. https://doi.org/10.1634/theoncologist.9-6-606
  2. Alizadeh AA, Ross DT, Perou CM, van de Rijn M. Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 2001; 195: 41-52. https://doi.org/10.1002/path.889
  3. Thor AD, Moore DH II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH, Smith HS. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 1992; 84: 845-55. https://doi.org/10.1093/jnci/84.11.845
  4. Bergh J, Norberg T, Sjogren S, Lindgren A, Holmberg L. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med 1995; 1: 1029-34. https://doi.org/10.1038/nm1095-1029
  5. Silvestrini R, Veneroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, Di Fronzo G, Rilke F, Veronesi U. The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst 1994; 86: 499-504. https://doi.org/10.1093/jnci/86.7.499
  6. Zhang GJ, Tsuda H, Adachi I, Fukutomi T, Yamamoto H, Hirohashi S. Prognostic indicators for breast cancer patients with one to three regional lymph node metastases, with special reference to alterations in expression levels of bcl-2, p53 and c-erbB-2 proteins. Jpn J Clin Oncol 1997; 27: 371-7. https://doi.org/10.1093/jjco/27.6.371
  7. Chen HH, Su WC, Guo HR, Chang TW, Lee WY. p53 and c-erbB- 2 but not bcl-2 are predictive of metastasis-free survival in breast cancer patients receiving post-mastectomy adjuvant radiotherapy in Taiwan. Jpn J Clin Oncol 2002; 32: 332-9. https://doi.org/10.1093/jjco/hyf076
  8. Silvestrini R, Veneroni S, Benini E, Daidone MG, Luisi A, Leutner M, Maucione A, Kenda R, Zucali R, Veronesi U. Expression of p53, glutathione S-transferase-pi and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer. J Natl Cancer Inst 1997; 89: 639-45. https://doi.org/10.1093/jnci/89.9.639
  9. Noguchi S, Koyama H, Kasugai T, Tsukuma H, Tsuji N, Tsuda H, Akiyama F, Motomura K, Inaji H. A case-control study on risk factors for local recurrences of distant metastases in breast cancer patients treated with breast-conserving surgery. Oncology 1997; 54: 468- 74. https://doi.org/10.1159/000227605
  10. Elkhuizen PH, Voogd AC, van den Broek LC, Tan IT, van Houwelingen HC, Leer JW, van de Vijver MJ. Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: a case-control study of histological factors and alterations in oncogene expression. Int J Radiat Oncol Biol Phys 1999; 45: 73-83. https://doi.org/10.1016/S0360-3016(99)00158-3
  11. Choi DH, Kim S, Rimm DL, Carter D, Haffty BG. Immunohistochemical biomarkers in patients with early-onset breast carcinoma by tissue microarray. Cancer J 2005; 11: 404-11. https://doi.org/10.1097/00130404-200509000-00008
  12. Gasparini G, Barbareschi M, Doglioni C, Palma PD, Mauri FA, Boracchi P, Bevilacqua P, Caffo O, Morelli L, Verderio P, Pezzella F, Harris AL. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Clin Cancer Res 1995; 1: 189-98.
  13. Le MG, Mathieu MC, Douc-Rasy S, Le Bihan ML, Adb El All H, Spielmann M, Riou G. c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patients. Int J Cancer 1999; 84: 562-7. https://doi.org/10.1002/(SICI)1097-0215(19991222)84:6<562::AID-IJC4>3.0.CO;2-0
  14. Neri A, Marrelli D, Roviello F, DeMarco G, Mariani F, DeStefano A, Megha T, Caruso S, Corso G, Cioppa T, Pinto E. Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer. Breast Cancer Res Treat 2006; 99: 77-83. https://doi.org/10.1007/s10549-006-9183-2
  15. Turner BC, Gumbs AA, Carbone CJ, Carter D, Glazer PM, Haffty BG. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy. Cancer 2000; 88: 1091-8. https://doi.org/10.1002/(SICI)1097-0142(20000301)88:5<1091::AID-CNCR21>3.0.CO;2-Y
  16. Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Jpn J Clin Oncol 2005; 35: 126- 33. https://doi.org/10.1093/jjco/hyi039
  17. Rolland P, Spendlove I, Madjid Z, Rakha EA, Patel P, Ellis IO, Durrant L. The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer. Int J Cancer 2007; 120: 1311-7. https://doi.org/10.1002/ijc.22430
  18. Hellemans P, van Dam PA, Weyler J, van Oosterom AT, Buytaert P, van Marck E. Prognostic value of bcl-2 expression in invasive breast cancer. Br J Cancer 1995; 72: 354-60. https://doi.org/10.1038/bjc.1995.338
  19. Berardo MD, Elledge RM, de Moor C, Clark GM, Osborne CK, Allred DC. Bcl-2 and apoptosis in lymph node positive breast carcinoma. Cancer 1998; 82: 1296-302. https://doi.org/10.1002/(SICI)1097-0142(19980401)82:7<1296::AID-CNCR12>3.0.CO;2-1
  20. Callagy GM, Pharoah PD, Pinder SE, Hsu FD, Nielsen TO, Ragaz J, Ellis IO, Huntsman D, Caldas C. Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index. Clin Cancer Res 2006; 12: 2468-75. https://doi.org/10.1158/1078-0432.CCR-05-2719
  21. Haffty BG, Yang Q, Reiss M, Kearney T, Higgins SA, Weidhaas J, Harris L, Hait W, Toppmeyer D. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol 2006; 24: 5652-7. https://doi.org/10.1200/JCO.2006.06.5664
  22. Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, Bellon JR, Wong JS, Smith BL, Harris JR. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 2008; 26: 2373-8. https://doi.org/10.1200/JCO.2007.14.4287
  23. Freedman GM, Anderson PR, Li T, Nicolaou N. Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation. Cancer 2009; 115: 946-51. https://doi.org/10.1002/cncr.24094
  24. Tan DS, Marchio C, Jones RL, Savage K, Smith IE, Dowsett M, Reis- Filho JS. Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res Treat 2008; 111: 27-44. https://doi.org/10.1007/s10549-007-9756-8
  25. Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO. Prognostic markers in triple-negative breast cancer. Cancer 2007; 109: 25-32. https://doi.org/10.1002/cncr.22381
  26. Bidard FC, Matthieu MC, Chollet P, Raoefils I, Abrial C, Domont J, Spielmann M, Delaloge S, Andre F, Penault-Llorca F. p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes. Ann Oncol 2008; 19: 1261-5. https://doi.org/10.1093/annonc/mdn039

Cited by

  1. Individual and family factors associated with intention to quit among male Vietnamese American smokers: Implications for intervention development vol.36, pp.4, 2010, https://doi.org/10.1016/j.addbeh.2010.11.009
  2. Population Approaches to Improve Diet, Physical Activity, and Smoking Habits : A Scientific Statement From the American Heart Association vol.126, pp.12, 2010, https://doi.org/10.1161/cir.0b013e318260a20b
  3. Association of Sociodemographic Factors, Smoking-Related Beliefs, and Smoking Restrictions With Intention to Quit Smoking in Korean Adults: Findings From the ITC Korea Survey vol.22, pp.1, 2010, https://doi.org/10.2188/jea.je20110026
  4. Smoking Trajectories among Koreans in Seoul and California: Exemplifying a Common Error in Age Parameterization vol.13, pp.5, 2012, https://doi.org/10.7314/apjcp.2012.13.5.1851
  5. 지역사회 거주 노인의 금연의도 영향요인 vol.23, pp.4, 2010, https://doi.org/10.12799/jkachn.2012.23.4.358
  6. Prevalence and Factors Associated with Smoking Intentions among Non-smoking and Smoking Adolescents in Kota Tinggi, Johor, Malaysia vol.15, pp.10, 2014, https://doi.org/10.7314/apjcp.2014.15.10.4359
  7. 지역사회 거주 성인남성의 금연의도 관련요인 vol.26, pp.4, 2010, https://doi.org/10.12799/jkachn.2015.26.4.364
  8. A randomized controlled trial of a videoconferencing smoking cessation intervention for Korean American women: preliminary findings vol.8, pp.None, 2010, https://doi.org/10.2147/ijwh.s109819
  9. 금연 자기효능감 증진 프로그램이 흡연 급성관상동맥증후군 환자에게 미치는 효과 vol.24, pp.1, 2010, https://doi.org/10.5953/jmjh.2017.24.1.37
  10. 우리나라 성인 흡연자의 금연의도와 관련 요인: 2014년 국민건강영양조사 자료를 이용하여 vol.19, pp.3, 2010, https://doi.org/10.7586/jkbns.2017.19.3.178
  11. Factors associated with desire to quit smoking among Estonian physicians: Cross-sectional data of 2002 and 2014 vol.4, pp.7, 2010, https://doi.org/10.18332/tpc/93009
  12. 금연 공동주택 주민들의 정책 순응도와 흡연 관련 행태 변화 vol.45, pp.4, 2020, https://doi.org/10.5393/jamch.2020.45.4.221
  13. Household Smoking Restrictions, Time to First Cigarette and Tobacco Dependence vol.2021, pp.None, 2010, https://doi.org/10.1155/2021/5517773